Cholesgen logo — Pioneering the future of medicine through groundbreaking dru...

Cholesgen

Pioneering the future of medicine through groundbreaking drug development and advanced biopharmaceutical research.

Founded 2021 Series A Total: $100.00M Biotechnology, Pharmaceutical

General Information

Company Name Cholesgen
Founded Year 2021
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Cholesgen. To contact Cholesgen, visit cholesgen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cholesgen compare?

A PDF of Cholesgen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cholesgen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cholesgen

Cholesgen is a biopharmaceutical company founded in 2021 with a mission to revolutionize medicine through innovative drug development and advanced biopharmaceutical research. The company's dedication to pioneering new disease targets based on biochemistry, disease biology, medicinal chemistry, and clinical translational medicine sets it apart in the Biotechnology and Pharmaceutical industries. In June 2023, Cholesgen secured a significant CNY100.00M Series A investment from a syndicate of influential backers including Gaorong Capital, Dawu Venture Capital, AstraZeneca CICC Medical Industry Fund, Sany Innovation Investment, and Nanwan Baiao Fund. This injection of capital signifies a vote of confidence in Cholesgen's innovative approach to drug development and its potential to leave a lasting impact on the future of medicine.

Business keywords: biopharmaceutical research, drug development, innovative drugs, disease targets, biochemistry, medicinal chemistry, clinical translational medicine, pharmaceutical industry, medical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A CNY100.00M 5
Gaorong Capital, Dawu Venture Capital +3
06 Jun 2023

Cholesgen Alternatives & Competitors

View All Alternatives
Cholesgen vs

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clinical needs...

Series A
Biopharma, Biotechnology
Cholesgen vs

Innovation, in Expedition

Series C
24 employees
Biotechnology, Health Care
Cholesgen vs

Pioneering the future of pain, epilepsy, depression, and neurodegenerative treatment through innovat...

Series A
Biotechnology, Pharmaceutical

FAQ About Cholesgen

Pioneering the future of medicine through groundbreaking drug development and advanced biopharmaceutical research.
Cholesgen was founded in 2021.
Cholesgen operates in Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical research, drug development, innovative drugs and disease targets.
Cholesgen has completed 1 funding round, raising a total of $100.00M. The latest funding stage is Series A.
Top alternatives and competitors to Cholesgen include Yuanyin Bio, GenFleet Therapeutics, Leadopharma, Redx Pharma, Numerate. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cholesgen and Yuanyin Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cholesgen, https://bouncewatch.com/company/cholesgen, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes